Spiration Valve System

DEVICE4 trials

Sponsors

Olympus Corporation of the Americas

Conditions

EmphysemaEmpyhsemaPulmonary Air LeaksPulmonary Disease, Chronic Obstructive

Unknown Phase

Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function

CompletedNCT01812447

Olympus Corporation of the AmericasEmphysema

Start: 2013-06-30End: 2022-08-31Updated: 2024-05-31

The Spiration Valve System for the Treatment of Severe Emphysema

CompletedNCT01989182

Olympus Corporation of the AmericasEmpyhsema, Pulmonary Disease, Chronic Obstructive

Start: 2013-11-08End: 2017-03-31Updated: 2018-02-14

Spiration Valves Against Standard Therapy

TerminatedNCT02382614

Olympus Corporation of the AmericasPulmonary Air Leaks

Start: 2015-05-31End: 2022-02-28Updated: 2024-04-04

REACH SVS Control Patient Cross-Over Study

CompletedNCT02914340

Olympus Corporation of the AmericasEmphysema

Start: 2016-09-30End: 2018-09-30Updated: 2018-10-24

Related Papers

Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE

Annals of the American Thoracic Society2023-11-108 citations

Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

American Journal of Respiratory and Critical Care Medicine2019-07-31168 citations

An Unusual Complication of Long-term Endobronchial Valves Placed for Persistent Air Leak

Journal of Bronchology & Interventional Pulmonology2017-03-221 citations